Fluoroquinolones for the treatment of tuberculosis in children

Tuberculosis
Stephanie TheeH Simon Schaaf

Abstract

The fluoroquinolones are key components of current multidrug-resistant tuberculosis (MDR-TB) treatment regimens and are being evaluated in shortened treatment regimens as well as in the prevention of drug-resistant TB. The objective of this review was to identify existing evidence for the use of the fluoroquinolones ofloxacin, levofloxacin and moxifloxacin in the treatment of TB in children. Existing data from in vitro, animal and human studies consistently demonstrate the efficacy of the fluoroquinolones against Mycobacterium tuberculosis, with superiority of levofloxacin and moxifloxacin compared to ofloxacin. In vitro and murine studies demonstrated the potential of moxifloxacin to shorten drug-susceptible TB treatment, but in multiple randomized controlled trials shortened fluoroquinolone-containing regimens have not been non-inferior compared to standard therapy. Resistance occurs frequently via mutations in the gyrA gene, and emerges rapidly depending on the fluoroquinolone concentration, with newer more potent fluoroquinolones less likely to develop resistance. Emerging data from paediatric studies underlines the importance of fluoroquinolones in the treatment of MDR-TB in children. There is a paucity of pharmacokinetic ...Continue Reading

References

Nov 1, 1978·The Journal of Toxicological Sciences·H TatsumiK Ohnishi
Oct 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N RastogiP Cruaud
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·U B Schaad
Feb 1, 1991·Antimicrobial Agents and Chemotherapy·J H YukK R Sweeney
Jan 1, 1991·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J H Paton, D S Reeves
Jun 1, 1990·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·N Rastogi, M C Blom-Potar
Oct 1, 1990·The Journal of Antimicrobial Chemotherapy·H LodeP Koeppe
Sep 1, 1990·The Journal of Antimicrobial Chemotherapy·D Van Caekenberghe
Oct 1, 1990·Archives of Disease in Childhood·A P Winrow, G Supramaniam
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·W R BowieP J Jewesson
Oct 1, 1987·European Journal of Clinical Microbiology·J Texier-MaugeinC Bébéar
Jan 1, 1988·Reviews of Infectious Diseases·W ChristB Ulbrich
Jan 1, 1986·Current Medical Research and Opinion·M VerhoA Korn
Sep 1, 1987·Antimicrobial Agents and Chemotherapy·H LodeP Koeppe
Jan 1, 1987·Current Medical Research and Opinion·V MalerczykR Rangoonwala
Oct 1, 1995·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·H SaitoS Dekio
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·B JIJ Grosset
Jan 1, 1993·Drugs·J C Pechère
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·S E BerningC A Peloquin
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·B A MuellerL Bowman
Nov 26, 1994·BMJ : British Medical Journal·C Upton
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·S P KlemensM H Cynamon
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·S D GoodwinJ A Bartlett
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·G HayemJ J Pocidalo
Jan 1, 1996·Archives of Toxicology·C FörsterR Stahlmann
Jan 1, 1997·The Pediatric Infectious Disease Journal·B HampelH Schmidt
Feb 1, 1997·Clinical Pharmacokinetics·D N Fish, A T Chow
Dec 24, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E BurkhardtU B Schaad

❮ Previous
Next ❯

Citations

Oct 21, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ping XuJunhua Xu
Mar 13, 2016·Survey of Ophthalmology·Ae Ra KeeRupesh Agrawal
Jun 23, 2015·Clinical Pharmacology and Therapeutics·H S SchaafP R Donald
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Graham H Bothamley
May 28, 2016·The Journal of Antimicrobial Chemotherapy·Samiksha GhimireJan-Willem C Alffenaar
Aug 3, 2010·Infectious Disease Clinics of North America·Ben J Marais, H Simon Schaaf
Jul 28, 2016·Expert Opinion on Drug Safety·H Simon SchaafAnthony J Garcia-Prats
Aug 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Payam NahidAndrew Vernon
Mar 28, 2017·Expert Opinion on Pharmacotherapy·Helena RabieH Simon Schaaf
May 13, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ping XuJunhua Xu
Mar 23, 2018·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·You Jung ShinHyun Mee Ryu
May 23, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anthony J Garcia-PratsH Simon Schaaf
Aug 9, 2017·Antimicrobial Agents and Chemotherapy·Max TaubertUwe Fuhr
Jan 17, 2019·Expert Review of Respiratory Medicine·Jennifer Furin
Mar 1, 2019·Indian Journal of Pediatrics·Andrea T Cruz, Jeffrey R Starke
Oct 16, 2019·Antimicrobial Agents and Chemotherapy·Samantha DonnellanGiancarlo A Biagini
Mar 15, 2016·The Pediatric Infectious Disease Journal·Louvina E van der LaanAnthony J Garcia-Prats
Dec 28, 2017·Expert Review of Clinical Pharmacology·H Simon SchaafJames A Seddon
May 1, 2017·Archives of Pharmacal Research·Shahzaib AhamadMd Imtaiyaz Hassan
May 7, 2019·Journal of Chemotherapy·Tommaso MatucciElena Chiappini
May 22, 2020·ACS Medicinal Chemistry Letters·Claudia MugnainiJean-Denis Docquier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.